Difference between revisions of "Talk:Worth2116"
(Where did you go to university? <a href=" http://www.southeastmidlands.org.uk/sample-page/ ">maxalt 5 mg</a> He added that the commission granted Ormet relief with theunderstanding the aluminum compa) |
(I hate shopping <a href=" http://www.painttheparks.com/quest/ ">buy finasteride lt</a> Now, moving to guidance. Since Q3, total revenues finished according to our expectations. We are maintaining the) |
||
Line 1: | Line 1: | ||
− | + | I hate shopping <a href=" http://www.painttheparks.com/quest/ ">buy finasteride lt</a> Now, moving to guidance. Since Q3, total revenues finished according to our expectations. We are maintaining the midpoint of full year 2013 guidance of $5.190 billion and narrowing the range to between $5.175 billion and $5.205 billion representing year-over-year growth of 12% to 13%. Excluding pivotal and divestitures, our total revenue growth for 2013 is expected to be between 16% and 17%. Given our strong license revenue performance in the third quarter, license revenue for the full year is now expected to be within the range of $2.255 billion and $2.275 billion representing 8% to 9% growth as reported and 10% to 11% excluding pivotal and divestitures. In both cases, this represents an increase in the midpoint of guidance by approximately one half of a percentage point. |
Revision as of 08:05, 4 September 2014
I hate shopping <a href=" http://www.painttheparks.com/quest/ ">buy finasteride lt</a> Now, moving to guidance. Since Q3, total revenues finished according to our expectations. We are maintaining the midpoint of full year 2013 guidance of $5.190 billion and narrowing the range to between $5.175 billion and $5.205 billion representing year-over-year growth of 12% to 13%. Excluding pivotal and divestitures, our total revenue growth for 2013 is expected to be between 16% and 17%. Given our strong license revenue performance in the third quarter, license revenue for the full year is now expected to be within the range of $2.255 billion and $2.275 billion representing 8% to 9% growth as reported and 10% to 11% excluding pivotal and divestitures. In both cases, this represents an increase in the midpoint of guidance by approximately one half of a percentage point.